How about you pick out what you think is indefensible

New Post Public Reply Private Reply Replies (0) Message Board
Goosebumps RTB #84363
511
How about you pick out what you think is indefensible instead of alluding to the Conference calls as whole as misleading. Tell us what you find misleading not just suggest that they are in whole misleading. I believe that you will not be able to find misleading intention. The forward looking statements are just that. Not an intention of being misleading but data supported comments. It may be animal data or trial data but most if not all are supported by some data. CYDY doesn’t make unsupported claims as far as I have noticed. If you have one. Please bring it foreword to be dissected on the board. Making bold claims of unfounded comments doesn’t support your position.

Being positive as an investor as we are sometimes is about hope and belief in what we are invested in. There are some that border on the negative almost exclusively but that is their choice. Myself and others have a positive spin on our investment and choose to see the good in the results that have come to light so far.
Any investor that doesn’t believe in their investments has choices to sell at any time. 20/20 hindsight is something we all wish we had. Myself I have never sold a share and will wait for the investment to blossom when the right time is accomplished and Leronlimab is recognized for the trials it has shown to have great results. I believe in my investment because I follow the daily board and read and research everything that is brought foreword on both sides of all arguments. It’s called doing your due diligence. Maybe you have heard of this before?

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fedora and Clarion Boost Oncology Practice Performance

Updated Category News Views 0

Hell of a Pair-Up: Fedora and Clarion Focus on Oncology Well, here's a setup that doesn't scream about blue chip stocks—but it's swimming in opportunity all the same. Fedora Healthcare Solutions just shook hands with Clarion, cementing a deal that's piqued my interest for its potential to green-light some real progress for independent oncology practices. These are not...

Continue Reading
SVRN Taps Industry Vet Patrick O'Kain as COO

Updated Category News Views 16

SVRN Aims for New Heights with a Savvy Hire If there’s one thing veteran market-watchers like myself know, it’s that leadership shifts can tell you more about a company’s guts than any press release. SVRN (NASDAQ: SVRN), a name with one foot firmly in the world of digital assets, just snagged Patrick O’Kain for their COO spot. They're not playing around, folks,...

Continue Reading
Fluence Energy Lawsuit: Investors Face Key Deadline

Updated Category News Views 35

Fluence Energy Under Fire Fluence Energy, Inc., ain't having the best of times, folks. If you've been keeping an eye on the stock ticker NASDAQ:FLNC, you probably felt the shiver when the news of a securities fraud class action lawsuit hit the wire. This ain't about some minor slip-up. These allegations are rocking the boat hard. What's at Stake for Investors? Here's the...

Continue Reading
Lemon Grove Bans Bird Sales to Combat Cruelty

Updated Category News Views 78

A Bird's Eye View on Lemon Grove's Bold Stand The folks in Lemon Grove, California, just sent out a loud and clear message: put an end to the inhumane sale of birds in pet stores. With 65% of voters backing Measure E, they've decided that birds fly best when they aren't part of a retail circus. Under this new rule, stores can only put birds up for adoption if they're...

Continue Reading
NNB Nutrition Unveils Revolutionary Ingredient Advances

Updated Category News Views 53

Sweet Innovation in a Natural Package Gotta hand it to NNB Nutrition—they’re not just shaking things up; they’re blending it into a whole new flavor universe. At the SupplySide Global 2026 in Vegas, NNB threw down some hefty advancements that might make even ol' Rockefeller sit up and take notice. We're talking about SweetVantage®, their brand-new creation that's...

Continue Reading
Fleet Management Software: Poised for 251% Growth

Updated Category News Views 53

Explosive Growth Ahead in Fleet Management Software If you're thinking we're about to see a seismic shift in how fleets are managed, you're spot on. The fleet management software market, worth a modest USD 1.83 billion in 2026, is projected to skyrocket to USD 6.41 billion by 2033. We’re talking a solid 19.6% CAGR here, and that’s not some small potatoes. This isn’t...

Continue Reading
Guaranteed Income Policies Gain Traction Across States

Updated Category News Views 42

Big Wins for Guaranteed Income Programs Boy, isn't it fascinating watching the political gears turn to embrace concepts like guaranteed income? This wave of enthusiasm isn't just words and ideas; it's now showing up in election results and ballot measures in multiple states. From California to Pennsylvania, voters appear to dig the idea of direct cash assistance to those...

Continue Reading
Basildon Build-to-Rent Marks Progress for Starlight

Updated Category News Views 48

Basildon's New Housing Beacon Nears Completion No two construction milestones are the same, and Starlight Investments sure knows how to make theirs count. Reaching the skies with their project 'The Mercantile' in Basildon, the company has announced topping out—a significant phase in their build-to-rent development saga. With the structural peak reached, we're talking...

Continue Reading
Are BWIN, LFCR, PCRX Shareholder Deals Fair?

Updated Category News Views 113

What's Really Going On with BWIN, LFCR, and PCRX? Everyone talks about when there's smoke, there's fire. But in this case, it’s hard not to wonder if we're standing knee-deep in burning embers, or just a dusty old campfire. Halper Sadeh LLC is ringing the alarm bells for Baldwin Group, Lifecore Biomedical, and Pacira BioSciences, the trio tagged under NASDAQ: BWIN,...

Continue Reading
Crude Insight: Refining Margins Expand, LNG Orders Rise

Updated Category News Views 166

Refining Margins Stretch While LNG Orders Surge Well, folks, oil markets have sure been a rollercoaster lately. WTI futures danced all over the place, closing near $96 a barrel after brushing against both $93 and $99 earlier this week. Brent wasn't left out of the tango, setting at $103.60. Everyone's holding their breath each time these numbers come through. Energy...

Continue Reading
e Spotlight"> Continue Reading